Co-Diovan

Pajjiż: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Hydrochlorothiazide 12.5mg;  ; Valsartan 80mg;  ;  ;  

Disponibbli minn:

Novartis New Zealand Ltd

INN (Isem Internazzjonali):

Hydrochlorothiazide 12.5 mg

Dożaġġ:

12.5mg/80mg

Għamla farmaċewtika:

Film coated tablet

Kompożizzjoni:

Active: Hydrochlorothiazide 12.5mg   Valsartan 80mg       Excipient: Colloidal silicon dioxide Crospovidone Hypromellose Iron oxide red Iron oxide yellow Macrogol 8000 Magnesium stearate Powdered cellulose Purified talc Titanium dioxide

Unitajiet fil-pakkett:

Blister pack, PVC/PVDC with Aluminium foil,

Klassi:

Prescription

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Changzhou Pharmaceutical Factory

Indikazzjonijiet terapewtiċi:

Co-Diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. These fixed dose combinations should be used as second line.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC with Aluminium foil -   - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVDC/PE/PVC-Al -   - 36 months from date of manufacture stored at or below 30°C - Blister pack, PA/Al/PVC foil - 28 tablets - 36 months from date of manufacture stored at or below 30°C

Data ta 'l-awtorizzazzjoni:

1998-12-23